Frankfurt - Delayed Quote EUR
Biofrontera AG N (B8FK.F)
2.3100
-0.0400
(-1.70%)
At close: April 25 at 8:03:58 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
21,666
21,666
32,249
25,738
28,787
Cost of Revenue
5,327
5,327
6,243
4,757
3,913
Gross Profit
16,339
16,339
26,005
20,981
24,873
Operating Expense
22,281
22,281
21,224
19,390
60,213
Operating Income
-5,942
-5,942
4,781
1,591
-35,340
Net Non Operating Interest Income Expense
53
53
6
-162
-3,707
Pretax Income
-6,719
-6,719
-2,127
-43,210
35,683
Tax Provision
-2,369
-2,369
-1,758
956
2,397
Net Income Common Stockholders
-4,350
-4,350
-369
-44,166
37,747
Diluted NI Available to Com Stockholders
-4,350
-4,350
-369
-44,166
37,747
Basic EPS
-0.72
-0.72
-0.21
-16.17
13.66
Diluted EPS
-0.72
-0.72
-0.21
-16.17
13.46
Basic Average Shares
6,076.8620
6,076.8620
3,038.4310
2,736.9000
2,757.1880
Diluted Average Shares
6,076.8620
6,076.8620
3,038.4310
2,736.9000
2,823.2450
Total Operating Income as Reported
-5,941
-5,941
4,782
1,591
-35,341
Total Expenses
27,608
27,608
27,467
24,147
64,126
Net Income from Continuing & Discontinued Operation
-4,350
-4,350
-369
-44,166
37,747
Normalized Income
-4,350
-4,350
-369
-44,166
37,747
Interest Income
64
64
21
1
13
Interest Expense
11
11
15
163
3,720
Net Interest Income
53
53
6
-162
-3,707
EBIT
-6,708
-6,708
-2,112
-43,047
39,403
EBITDA
-5,869
-5,869
-1,321
-42,301
42,693
Reconciled Cost of Revenue
5,327
5,327
6,243
4,757
3,913
Reconciled Depreciation
839
839
791
746
3,290
Net Income from Continuing Operation Net Minority Interest
-4,350
-4,350
-369
-44,166
37,747
Normalized EBITDA
-5,869
-5,869
-1,321
-42,301
42,693
Tax Rate for Calcs
0.0004
0.0004
0.0002
0.0002
0.0001
12/31/2021 - 10/30/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade